Episode Details
Back to Episodes
RBC Biotech Analyst Leo Timashev shares his take on the sector and discusses companies he covers that are in the news
Published 5 months, 2 weeks ago
Description
He discusses Insmed, IDEAYA, Bicycle, Compass Pathways, Revolution Medicines, Cytokinetics, and CG Oncology